Serine derivatives as ghrelin receptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9873695
SERIAL NO

15316543

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example as modulators of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSR1a receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RAQUALIA PHARMA INC1-21-19 MEIEKI MINAMI NAKAMURA-KU NAGOYA-SHI AICHI 4500003

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Iwata, Yasuhiro Aichi, JP 47 583
Kawamura, Kiyoshi Aichi, JP 87 1257
Koizumi, Shinichi Aichi, JP 33 166
Kuroda, Makiko Aichi, JP 3 4
Obata, Keiko Aichi, JP 2 0
Shimada, Kaoru Aichi, JP 30 93
Sudo, Masaki Aichi, JP 18 26
Takahashi, Nobuyuki Aichi, JP 316 4437

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 23, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 23, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00